News
Filtrar por
Content with Year .
Press Release
VaxThera, GC Biopharma and RIGHT Foundation Advance Influenza Vaccine Technology Transfer in Colombia
The project brings together international funding, proven vaccine expertise and local capabilities to strengthen vaccine manufacturing in Colombia and Latin America.
More information
Press Release
EIB, European Commission and VaxThera boost Latin America’s vaccine capacity by up to 250 million doses a year
The financing will support the expansion of an integrated manufacturing facility, enabling VaxThera to produce up to 250 million doses per year.
More information
Press release
VaxThera and Codagenix Partner to Advance a Next Generation Yellow Fever Vaccine
VaxThera will further advance Syn17D-YF, the world’s first fully synthetic yellow fever vaccine candidate designed for modern cell-culture manufacturing.
More information
Statement
VaxThera and Hetero announce strategic alliance to expand access to high-cost biologic therapies
Collaboration begins with three monoclonal antibodies and establishes a pathway toward technology transfer and local production in Colombia for Latin America
More information
Noticia
VaxThera and Serum Institute of India Announce a Strategic Collaboration to Strengthen Vaccine Development and Health Security in Colombia
This collaboration represents a historic step forward for Colombia. Together, VaxThera and the Serum Institute of India will launch a collaborative program.
More information
Comunicado
VaxThera Achieves LEED® Gold Certification for Its Manufacturing Facility, Reinforcing Its Commitment to Sustainability
With a design focused on water and energy efficiency, VaxThera has achieved LEED Gold certification, validated by GBCI
More information